Evidence map›Paper›PMID 30775231›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Peptide-siRNA Supramolecular Particles for Neural Cell Transfection.

Armando Hernandez-Garcia, Zaida Álvarez, Dina Simkin, Ashwin Madhan, Eloise Pariset, Faifan Tantakitti, Oscar de J Vargas-Dorantes, Sungsoo S Lee, Evangelos Kiskinis, Samuel I Stupp

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Lauroylated Histidine-Enriched S4Pharmaceutical research · 2020
    Article
  3. Peptide-siRNA Supramolecular Particles for Neural Cell Transfection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Armando Hernandez-GarciaSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.ORCID https://orcid.org/0000-0002-2401-8139
Zaida ÁlvarezSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.ORCID https://orcid.org/0000-0001-5104-1388
Dina SimkinDepartment of Pharmacology Feinberg School of Medicine Northwestern University Chicago IL 60611 USA.ORCID https://orcid.org/0000-0002-4473-5960
Ashwin MadhanSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.
Eloise ParisetSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.
Faifan TantakittiSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.
Oscar de J Vargas-DorantesDepartment of Chemistry of Biomacromolecules Institute of Chemistry National Autonomous University of Mexico Ciudad Universitaria Mexico City 04510 Mexico.
Sungsoo S LeeSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.
Evangelos KiskinisThe Ken & Ruth Davee Department of Neurology & Clinical Neurological Sciences Department of Physiology Feinberg School of Medicine Northwestern University Chicago IL 60611 USA.ORCID https://orcid.org/0000-0001-8342-8616
Samuel I StuppSimpson Querrey Institute Northwestern University Chicago IL 60611 USA.ORCID https://orcid.org/0000-0002-5491-7442
Northwestern University · USUniversidad Autónoma de la Ciudad de México · MX

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
Regenerative Scaffold Technologies for CNS and DiabetesR01EB003806 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI STUPP, SAMUEL I · 2004 to 2015
$10.7M
NCI NIH HHS P30 CA060553NIBIB NIH HHS R01 EB003806
6 · The paper itself

Abstract

Small interfering ribonucleic acid (siRNA)-based gene knockdown is an effective tool for gene screening and therapeutics. However, the use of nonviral methods has remained an enormous challenge in neural cells. A strategy is reported to design artificial noncationic modular peptides with amplified affinity for siRNA via supramolecular assembly that shows efficient protein knockdown in neural cells. By solid phase synthesis, a sequence that binds specifically double-stranded ribonucleic acid (dsRNA) with a self-assembling peptide for particle formation is integrated. These supramolecular particles can be further functionalized with bioactive sequences without affecting their biophysical properties. The peptide carrier is found to silence efficiently up to 83% of protein expression in primary astroglial and neuronal cell cultures without cytotoxicity. In the case of neurons, a reduction in electrical activity is observed once the presynaptic protein synaptophysin is downregulated by the siRNA-peptide particles. The results demonstrate that the supramolecular particles offer an siRNA delivery platform for efficient nonviral gene screening and discovery of novel therapies for neural cells.

Indexed as

glial cellsglial fibrillary acidic protein (GFAP)knockdownneuronsprotein engineeringsupramolecular particlessynaptophysintransfection

Identifiers

PMID30775231
PMCPMC6364495
OpenAlexW2903404807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.